Exploring the Endocannabinoid System in Mental Health Treatment Research
This article reviews recent endocannabinoid system mental health research focusing on its role in psychiatric disorders. Current studies explore how this system influences mental health treatment outcomes. Understanding these mechanisms may guide future…
Clinical Trial of CBD Oil Effects on Autism and Anxiety
The CBD oil autism anxiety trial demonstrated measurable improvements in social relating and anxiety symptoms in autistic children. This randomized controlled study used a weight-based dosing approach over 12 weeks. Findings suggest potential benefits of…
Understanding Cannabis-Induced Psychosis and Psychiatric Progression
Cannabis-induced psychosis schizophrenia bipolar progression is a critical clinical concern. Patients with cannabis-induced psychosis have measurable risk for schizophrenia spectrum or bipolar disorder. Long-term monitoring is essential to identify those…
Clinical Trials of CBD for Anxiety and Tourette
CBD anxiety clinical trials demonstrate promising efficacy for generalized and social anxiety disorders with good safety. THC formulations show mixed results and possible anxiety worsening at high doses. Current evidence supports CBD as an adjunctive…
Digital Smoking Cessation Programs in HIV Care
Digital smoking cessation programs HIV provide tailored support for people living with HIV. These programs enable remote access to evidence-based cessation tools. Digital therapeutics show promising effectiveness in this underserved population.
Cannabidiol Supplements and WADA-Prohibited Cannabinoids
Broad-spectrum CBD supplements doping risk athletes face is a growing concern due to detectable prohibited cannabinoids in urine and blood. Exercise may amplify cannabinoid absorption or excretion, increasing detection risk. Athletes should verify…
How Cannabidiol Modulates Glutamate in Psychosis Risk
A single dose of cannabidiol glutamate modulation psychosis effects was studied in people at clinical high risk for psychosis. CBD reduced abnormal hippocampal glutamate connections and irregular brain activity during memory tasks. This suggests…
Cannabis Dosing and Tolerability in AIMSS Treatment
This study evaluates aromatase inhibitor joint pain relief using topical cannabis balms in women with AIMSS. The balms were well tolerated and showed promising results. Further research is needed to confirm efficacy and safety.
Clinical Evidence on Cannabidiol Drug Interactions and Safety
Cannabidiol drug interactions have minimal clinical significance in cancer patients using multiple medications. Current evidence from controlled trials shows no adverse changes in drug metabolism or event rates with standard CBD doses. Healthcare…
Cannabinoid Pain Relief: Clinical Evidence Review
Clinical Takeaway Cannabinoids modulate pain signaling by affecting sodium channels involved in nerve impulse transmission, which represents a specific mechanism for pain relief. This action occurs at ion channels that are critical for transmitting pain…